Vision HSL Instrument for PBMC Counting

The Centers for Disease Control and Prevention, NCIRD/DVD, 1600 Clifton Rd. NE, Atlanta, GA, 30333, hereby announces its intent to issue a sole source contract in accordance with FAR 6.302-1 to Nexcelom Biosciences, LLC, 360 Merrimack St, Lawrence, MA 01843, to acquire a Vision HSL Instrument for Influenza testing. The statutory authority permitting other than full and open competition is 41 U.S.C. 253(c)(1) as cited in FAR 6.302-1, "Only one responsible source and no other supplies or services will satisfy agency requirements." The National Center for Immunization and Respiratory Disease (NCIRD) has a requirement to acquire a Vision HSL Instrument. This is the only piece of PBMC counting equipment that will satisfy existing laboratory protocols and requirements for scientific accuracy. This product is necessary to evaluate the efficacy of the influenza virus in human clinical trials, and ultra-accuracy is required for the readings. Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 3 days from the posting date of this notice, their written capabilities statement, proposal or quotation which shall be considered by the agency. Please forward the capability statement and/or pricing information to David Dombeck, Contract Officer, Reference 2015-80812, Centers for Disease Control, Procurement and Grants Office, ATTN: David Dombeck, MS: K-14, 2920 Brandywine Road, Atlanta, GA 30341. All vendors must be registered in the System for Award Management (SAM) prior to an award of a federal contract. The website is: www.sam.gov. The Government will review any/all capabilities statements and pricing information submitted and determine if other qualified sources do exist that could provide this requirement. Information received in response to this announcement will be used solely for the purpose of determining whether to conduct a competitive procurement. If no affirmative responses are received within 3 days, negotiations will be conducted with Nexcelom Biosciences, LLC, as the only source and a contract will be issued without any additional notices being posted.